DLL3 — Delta-Like 3
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">DLL3</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>DLL3</td></tr>
<tr><td><strong>Full Name</strong></td><td>Delta-Like 3</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>19q13.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[27197](https://www.ncbi.nlm.nih.gov/gene/27197)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[604579](https://www.omim.org/entry/604579)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000090932</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9NZU6](https://www.uniprot.org/uniprot/Q9NZU6)</td></tr>
<tr><td><strong>Protein Name</strong></td><td>Delta-like protein 3</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), Spondylocostal Dysostosis, Neurodevelopmental Disorders, [Parkinson's Disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>
Overview
DLL3 encodes Delta-like protein 3, a membrane-bound ligand for [Notch receptors](/mechanisms/notch-signaling-pathway) that plays crucial roles in embryonic neurodevelopment, somite segmentation, and boundary formation in the nervous system. Unlike other DLL family members, DLL3 has unique inhibitory functions in the Notch pathway, primarily localizing to the Golgi apparatus and acting as a negative regulator of Notch signaling[@chiba2008].
...DLL3 — Delta-Like 3
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">DLL3</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>DLL3</td></tr>
<tr><td><strong>Full Name</strong></td><td>Delta-Like 3</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>19q13.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[27197](https://www.ncbi.nlm.nih.gov/gene/27197)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[604579](https://www.omim.org/entry/604579)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000090932</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9NZU6](https://www.uniprot.org/uniprot/Q9NZU6)</td></tr>
<tr><td><strong>Protein Name</strong></td><td>Delta-like protein 3</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), Spondylocostal Dysostosis, Neurodevelopmental Disorders, [Parkinson's Disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>
Overview
DLL3 encodes Delta-like protein 3, a membrane-bound ligand for [Notch receptors](/mechanisms/notch-signaling-pathway) that plays crucial roles in embryonic neurodevelopment, somite segmentation, and boundary formation in the nervous system. Unlike other DLL family members, DLL3 has unique inhibitory functions in the Notch pathway, primarily localizing to the Golgi apparatus and acting as a negative regulator of Notch signaling[@chiba2008].
The DLL3 gene is essential for proper somite segmentation during embryonic development and is expressed in the developing nervous system. Recent research has revealed that DLL3 and the Notch pathway are dysregulated in several neurodegenerative diseases, including [Alzheimer's Disease](/diseases/alzheimers-disease) and [Parkinson's Disease](/diseases/parkinsons-disease), where they contribute to impaired neurogenesis, neuroinflammation, and neuronal dysfunction[@lavas2019].
Molecular Biology
Gene Structure
The DLL3 gene is located on chromosome 19q13.2 and consists of 8 exons spanning approximately 8 kb. It encodes a type I transmembrane protein of 667 amino acids with a molecular weight of approximately 75 kDa.
Protein Structure
The DLL3 protein contains several characteristic domains:
N-terminal Delta-Serrate-Lag2 (DSL) Domain: Conserved region (~95 aa) responsible for Notch receptor binding
EGF-like Repeats: Six epidermal growth factor-like repeats that mediate protein-protein interactions
Transmembrane Domain: Single-pass membrane anchor (~22 aa)
Intracellular Domain: Short cytoplasmic tail (~40 aa) with unknown functionDSL Domain Function
The DSL domain mediates specific interactions with Notch receptors:
- Notch1: Primary receptor for DLL3
- Notch2: Secondary receptor
- Notch3: Lower affinity interaction
Unusual Cellular Localization
Unlike other Notch ligands, DLL3 exhibits unique localization:
- Golgi Apparatus: Primary location
- Plasma Membrane: Limited presence
- Secretory Vesicles: Some reports
This Golgi localization contributes to DLL3's inhibitory function, as it may sequester Notch receptors in intracellular compartments.
Role in Notch Signaling
Canonical Notch Pathway
The Notch signaling pathway is a conserved cell-cell communication mechanism:
Ligand Binding: DLL3 binds to Notch receptors on adjacent cells
Proteolytic Cleavage: γ-secretase releases Notch intracellular domain (NICD)
Nuclear Translocation: NICD enters the nucleus
Transcription Activation: Co-activator recruitment and target gene expressionDLL3 as a Notch Inhibitor
DLL3 functions differently from other Notch ligands:
Golgi Sequestration: DLL3 localizes Notch receptors to the Golgi
Inhibitory Signaling: Can function as a dominant-negative inhibitor
cis-Inhibition: Can inhibit Notch in the same cell (cis-acting)
Jagged1 Competition: Competes with activating ligandsTarget Genes
Notch signaling regulates numerous genes:
| Gene Category | Examples | Function |
|---------------|----------|----------|
| Transcription Factors | Hes1, Hey1, Hey2 | Developmental timing |
| Cell Cycle Regulators | Cyclin D1, p21 | Proliferation control |
| Signaling Molecules | Jagged1, DLL1 | Feedback regulation |
| Effector Proteins | Hes5, Dll1 | Notch output |
Role in Neurodevelopment
Somite Segmentation
DLL3 is critical for somite formation during embryogenesis:
Segmentation Clock: DLL3 expression oscillates with the segmentation clock
Boundary Formation: Establishes somite boundaries
Anterior-Posterior Patterning: Determines somite polarity
Vertebra Formation: Segmental patterning of axial skeletonNeural Development
DLL3 in the developing nervous system:
Neurogenesis: Regulates neural progenitor proliferation
Neuronal Differentiation: Controls timing of neuron formation
Glial Fate: Influences astrocyte versus neuron specification
Axon Guidance: May affect axon pathfindingBrain Development
- Ventral Telencephalon: NPC maintenance
- Cerebellar Development: Granule cell precursors
- Cortical Neurogenesis: Layer-specific patterning
Role in Neurodegeneration
Alzheimer's Disease
DLL3 dysregulation contributes to AD pathogenesis through multiple mechanisms[@anderson2020]:
Neurogenesis Impairment
- Notch signaling in adult neurogenesis
- Hippocampal NPC dysfunction
- Reduced neuronal production
Amyloid Processing
- Notch interacts with APP processing
- γ-secretase duality (APP vs Notch)
- Aβ effects on Notch signaling
Tau Pathology
- Notch-tau crosstalk
- Phosphorylation effects
- NFT formation connections
Synaptic Dysfunction
- Notch in synaptic plasticity
- LTP modulation
- Memory consolidation
Parkinson's Disease
In [Parkinson's Disease](/diseases/parkinsons-disease):
Dopaminergic Development
- Notch in substantia nigra development
- Developmental vulnerability
- Regeneration potential
Alpha-Synuclein Connection
- Notch signaling effects on [alpha-synuclein](/proteins/alpha-synuclein)
- Protein aggregation interactions
Neuroinflammation
- Microglial Notch activation
- Inflammatory gene expression
Neuroinflammation
Notch signaling modulates neuroinflammation[@sweeney2021]:
Microglial Activation
- NF-κB cross-talk
- Cytokine production
- Phagocytosis regulation
Astrocyte Function
- Inflammatory responses
- Reactive gliosis
- Neurotoxicity
Peripheral Immune
- T-cell infiltration
- Adaptive immunity
Expression Patterns
Tissue Distribution
DLL3 expression:
- Embryonic Tissues: Highest during development
- Brain: Neural progenitors, certain neurons
- Somites: Precursor structures
- Low Adult Expression: Most tissues
Brain Region Specificity
- Ventricles: Subventricular zone
- Hippocampus: Dentate gyrus subgranular zone
- Cerebellum: External granule layer
- Cortex: Subpial population
Cellular Localization
- Golgi Apparatus: Primary location
- Plasma Membrane: Limited
- Endoplasmic Reticulum: Some reports
Therapeutic Implications
Targeting Notch-DLL3 in Neurodegeneration
Notch Inhibitors: γ-secretase inhibitors
DLL3 Modulators: Agonists or antagonists
DLL3-Targeting Antibodies: Therapeutic antibodiesDrug Development Strategies
| Strategy | Approach | Disease |
|----------|----------|---------|
| γ-Secretase Inhibitors | Block Notch cleavage | AD, cancer |
| DLL3 Antibodies | Neutralize DLL3 | SCD, tumors |
| Notch Agonists | Enhance signaling | PD regeneration |
| DLL3 Agonists | Activate Notch | AD neurogenesis |
Clinical Considerations
- Notch pathway complexity
- Multiple receptor-ligand interactions
- Tissue-specific effects
- Developmental toxicity
Interaction Network
Notch Receptors
- [NOTCH1](/proteins/notch1) - Primary receptor
- [NOTCH2](/proteins/notch2) - Secondary receptor
- [NOTCH3](/proteins/notch3) - CNS expression
Other Notch Ligands
- DLL1: Activating ligand
- DLL4: Activating ligand
- JAG1: Activating ligand (Jagged1)
- JAG2: Activating ligand (Jagged2)
Signaling Partners
- NICD: Notch intracellular domain
- CSL/RBPJκ: Transcription factor
- MAML: Co-activator
- HES/HEY: Target transcription factors
DLL3-Specific Interactors
- Fringe Modifiers: OFUT1, LFNG
- Mindbomb: E3 ubiquitin ligase
- NUMB: Negative regulator
Animal Models
Knockout Studies
- DLL3 KO mice: Lethal (severe somite defects)
- Phenotype: Defective segmentation
- Mosaic models: Viable for analysis
Transgenic Models
- DLL3 overexpression: Dominant-negative effects
- DLL3 mutants: Human disease models
Disease Models
- AD models: Notch changes observed
- PD models: DLL3 alterations
Therapeutic Models
- γ-secretase inhibitor: Effects on neurogenesis
- DLL3 antibodies: Preclinical testing
Clinical Significance
Spondylocostal Dysostosis
DLL3 mutations cause autosomal dominant spondylocostal dysostosis (SCD):
- Genetics: Heterozygous DLL3 mutations
- Phenotype: Vertebral segmentation defects
- Inheritance: Autosomal dominant
- Penetrance: Variable expressivity
Biomarker Potential
- DLL3 expression as disease marker
- Notch pathway activation status
- Neurogenesis assessment
Diagnostic Applications
- Disease classification
- Progression monitoring
- Therapeutic targeting
Research Findings
| Year | Finding | Model/Context |
|------|---------|---------------|
| 2000 | DLL3 mutations cause SCD | Human genetics |
| 2004 | DLL3 in somite segmentation | Mouse models |
| 2008 | Notch ligand specificity | Cell biology |
| 2014 | DLL3 in CNS development | Mouse models |
| 2019 | Notch in neurodegeneration | Review |
| 2020 | DLL3-Notch in AD | Human tissue |
| 2022 | Notch modulation in AD | Preclinical |
Disease Mechanisms Summary
Alzheimer's Disease Pathogenesis
DLL3 contributes to AD through:
Neurogenesis Dysregulation
- Adult NPC function
- Hippocampal plasticity
- Memory formation
Notch-Aβ Cross-talk
- γ-secretase substrate competition
- Aβ effects on Notch
- Signaling impairment
Neuroinflammation
- Microglial activation
- Cytokine production
Parkinson's Disease Pathogenesis
DLL3 involvement in PD:
Developmental Vulnerability
- Dopaminergic neuron development
- Circuit formation
Adult Neurogenesis
- Subventricular zone function
- Replacement potential
Inflammatory Modulation
Cross-Links
- [Notch Signaling Pathway](/mechanisms/notch-signaling-pathway)
- [Neurodevelopment](/mechanisms/neurodevelopment)
- [Alzheimer's Disease Mechanisms](/diseases/alzheimers-disease)
- [Parkinson's Disease Mechanisms](/diseases/parkinsons-disease)
- [NOTCH1](/proteins/notch1)
- [NOTCH2](/proteins/notch2)
- [DLL1](/proteins/dll1-protein)
- [Neurogenesis](/mechanisms/adult-neurogenesis)
See Also
- [Genes Index](/genes)
- [Proteins Index](/proteins)
- [Mechanisms Index](/mechanisms)
- [Developmental Pathways](/mechanisms/neurodevelopment)
External Links
- NCBI Gene: [27197](https://www.ncbi.nlm.nih.gov/gene/27197)
- Ensembl: [ENSG00000090932](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000090932)
- UniProt: [Q9NZU6](https://www.uniprot.org/uniprot/Q9NZU6)
- GeneCards: [DLL3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=DLL3)
- OMIM: [604579](https://www.omim.org/entry/604579)
References
[Bulman MP, et al. DLL3 mutations in spondylocostal dysostosis (2000)](https://pubmed.ncbi.nlm.nih.gov/10893227/)
[Kusumi K, et al. DLL3 in somitogenesis (2004)](https://pubmed.ncbi.nlm.nih.gov/15077114/)
[Chiba S, et al. DLL3 function in Notch signaling (2008)](https://pubmed.ncbi.nlm.nih.gov/18684702/)
[Holland JD, et al. DLL3 in CNS development (2014)](https://pubmed.ncbi.nlm.nih.gov/24615695/)
[Lavas M, et al. Notch signaling in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31153924/)
[Anderson A, et al. DLL3 and Notch in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32723338/)
[Sweeney NM, et al. Notch pathway in neuroinflammation (2021)](https://pubmed.ncbi.nlm.nih.gov/34246384/)
[DLL3 and somite boundary formation (2016)](https://pubmed.ncbi.nlm.nih.gov/27060054/)
[Notch in adult neurogenesis (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)
[DLL3 therapeutic targeting (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)Pathway Diagram
The following diagram shows the key molecular relationships involving dll3 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Pathway Diagram
The following diagram shows the key molecular relationships involving DLL3 — Delta-Like 3 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)